The Relationship Between the Tumor Markers and Interstitial Lung Disease
NCT04597814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2020-10-23
Summary
The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients.
This study was undertaken to investigate the source of these serum tumor markers.
Conditions
- the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
-
The First Affiliated Hospital of Guangzhou Medical University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2020-10-15
- Completion
- 2020-10-15
Countries
- China
Study Locations
More Related Trials
-
Predictive Value of CEA and ctDNA in Lung Cancer Recurrence
NCT07170046 ·Status: NOT_YET_RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
irAE Prediction of Anti-PD-1/L1 in Lung Cancer
NCT05288569 ·Status: UNKNOWN
-
A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma
NCT05984017 ·Status: RECRUITING
-
Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma
NCT06645743 ·Status: NOT_YET_RECRUITING
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Study of CT and MR in the Lung Cancer
NCT04034667 ·Status: UNKNOWN
-
Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
NCT02458651 ·Status: COMPLETED
-
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977 ·Status: RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
NCT03465241 ·Status: COMPLETED
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring
NCT02437760 ·Status: UNKNOWN
-
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
NCT02501668 ·Status: COMPLETED
-
Prospective Study of Serum Marker LncRNA RP5-977B1 in Pulmonary Nodules
NCT06531850 ·Status: RECRUITING
-
A Prognosis and Predicting Genetic Study of Lung Cancer
NCT03234179 ·Status: NOT_YET_RECRUITING
-
Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning Rock
NCT03337711 ·Status: UNKNOWN
-
Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer
NCT05278754 ·Status: UNKNOWN
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease
NCT03101397 ·Status: UNKNOWN
-
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
NCT05252065 ·Status: UNKNOWN
-
Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
NCT07257471 ·Status: RECRUITING
-
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC
NCT05637580 ·Status: COMPLETED